These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Does immunotherapy increase the rate of radiation necrosis after radiosurgical treatment of brain metastases? Colaco RJ; Martin P; Kluger HM; Yu JB; Chiang VL J Neurosurg; 2016 Jul; 125(1):17-23. PubMed ID: 26544782 [TBL] [Abstract][Full Text] [Related]
45. Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study. Valpione S; Carlino MS; Mangana J; Mooradian MJ; McArthur G; Schadendorf D; Hauschild A; Menzies AM; Arance A; Ascierto PA; Di Giacomo A; de Rosa F; Larkin J; Park JJ; Goldinger SM; Sullivan RJ; Xu W; Livingstone E; Weichenthal M; Rai R; Gaba L; Long GV; Lorigan P Eur J Cancer; 2018 Mar; 91():116-124. PubMed ID: 29360604 [TBL] [Abstract][Full Text] [Related]
46. BRAF-V600 mutational status affects recurrence patterns of melanoma brain metastasis. Maxwell R; Garzon-Muvdi T; Lipson EJ; Sharfman WH; Bettegowda C; Redmond KJ; Kleinberg LR; Ye X; Lim M Int J Cancer; 2017 Jun; 140(12):2716-2727. PubMed ID: 27342756 [TBL] [Abstract][Full Text] [Related]
47. The combination of stereotactic radiosurgery with immune checkpoint inhibition or targeted therapy in melanoma patients with brain metastases: a retrospective study. Martins F; Schiappacasse L; Levivier M; Tuleasca C; Cuendet MA; Aedo-Lopez V; Gautron Moura B; Homicsko K; Bettini A; Berthod G; Gérard CL; Wicky A; Bourhis J; Michielin O J Neurooncol; 2020 Jan; 146(1):181-193. PubMed ID: 31836957 [TBL] [Abstract][Full Text] [Related]
48. Sequential treatment with immunotherapy and BRAF inhibitors in BRAF-mutant advanced melanoma. Aya F; Fernandez-Martinez A; Gaba L; Victoria I; Tosca M; Pineda E; Gascon P; Prat A; Arance A Clin Transl Oncol; 2017 Jan; 19(1):119-124. PubMed ID: 27147251 [TBL] [Abstract][Full Text] [Related]
49. Concurrent Administration of Immune Checkpoint Inhibitors and Single Fraction Stereotactic Radiosurgery in Patients With Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma Brain Metastases. Lehrer EJ; Kowalchuk RO; Gurewitz J; Bernstein K; Kondziolka D; Niranjan A; Wei Z; Lunsford LD; Fakhoury KR; Rusthoven CG; Mathieu D; Trudel C; Malouff TD; Ruiz-Garcia H; Bonney P; Hwang L; Yu C; Zada G; Patel S; Deibert CP; Picozzi P; Franzini A; Attuati L; Prasad RN; Raval RR; Palmer JD; Lee CC; Yang HC; Harmsen WS; Jones BM; Sharma S; Ahluwalia MS; Sheehan JP; Trifiletti DM Int J Radiat Oncol Biol Phys; 2023 Jul; 116(4):858-868. PubMed ID: 36690161 [TBL] [Abstract][Full Text] [Related]
50. Stereotactic radiosurgery combined with immune checkpoint inhibitors or kinase inhibitors for patients with multiple brain metastases of malignant melanoma. Stera S; Balermpas P; Blanck O; Wolff R; Wurster S; Baumann R; Szücs M; Loutfi-Krauss B; Wilhelm ML; Seifert V; Rades D; Rödel C; Dunst J; Hildebrandt G; Arnold A; Meissner M; Kähler KC Melanoma Res; 2019 Apr; 29(2):187-195. PubMed ID: 30802230 [TBL] [Abstract][Full Text] [Related]
51. Hypofractionated stereotactic radiosurgery (HSRS) as a salvage treatment for brain metastases failing prior stereotactic radiosurgery (SRS). Yan M; Lee M; Myrehaug S; Tseng CL; Detsky J; Chen H; Das S; Yeboah C; Lipsman N; Costa LD; Holden L; Heyn C; Maralani P; Ruschin M; Sahgal A; Soliman H J Neurooncol; 2023 Mar; 162(1):119-128. PubMed ID: 36914878 [TBL] [Abstract][Full Text] [Related]
52. Stereotactic radiosurgery and immunotherapy in melanoma brain metastases: Patterns of care and treatment outcomes. Gabani P; Fischer-Valuck BW; Johanns TM; Hernandez-Aya LF; Keller JW; Rich KM; Kim AH; Dunn GP; Robinson CG; Chicoine MR; Huang J; Abraham CD Radiother Oncol; 2018 Aug; 128(2):266-273. PubMed ID: 29960685 [TBL] [Abstract][Full Text] [Related]
53. Stereotactic radiosurgery for patients with multiple brain metastases: a case-matched study comparing treatment results for patients with 2-9 versus 10 or more tumors. Yamamoto M; Kawabe T; Sato Y; Higuchi Y; Nariai T; Watanabe S; Kasuya H J Neurosurg; 2014 Dec; 121 Suppl():16-25. PubMed ID: 25434933 [TBL] [Abstract][Full Text] [Related]
54. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Chang EL; Wefel JS; Hess KR; Allen PK; Lang FF; Kornguth DG; Arbuckle RB; Swint JM; Shiu AS; Maor MH; Meyers CA Lancet Oncol; 2009 Nov; 10(11):1037-44. PubMed ID: 19801201 [TBL] [Abstract][Full Text] [Related]
55. Cumulative Intracranial Tumor Volume and Number of Brain Metastasis as Predictors of Developing New Lesions After Stereotactic Radiosurgery for Brain Metastasis. Sharma M; Jia X; Ahluwalia M; Barnett GH; Vogelbaum MA; Chao ST; Suh JH; Murphy ES; Yu JS; Angelov L; Mohammadi AM World Neurosurg; 2017 Oct; 106():666-675. PubMed ID: 28735139 [TBL] [Abstract][Full Text] [Related]
56. Incidence of radionecrosis in single-fraction radiosurgery compared with fractionated radiotherapy in the treatment of brain metastasis. Donovan EK; Parpia S; Greenspoon JN Curr Oncol; 2019 Jun; 26(3):e328-e333. PubMed ID: 31285676 [TBL] [Abstract][Full Text] [Related]
57. Improved Overall Survival and Locoregional Disease Control With Concurrent PD-1 Pathway Inhibitors and Stereotactic Radiosurgery for Lung Cancer Patients With Brain Metastases. Schapira E; Hubbeling H; Yeap BY; Mehan WA; Shaw AT; Oh K; Gainor JF; Shih HA Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):624-629. PubMed ID: 29678530 [TBL] [Abstract][Full Text] [Related]
58. Stereotactic Radiosurgery for Melanoma Brain Metastases: A Comprehensive Clinical Case Series. Feng R; Oermann EK; Shrivastava R; Gold A; Collins BT; Kondziolka D; Collins SP World Neurosurg; 2017 Apr; 100():297-304. PubMed ID: 28093345 [TBL] [Abstract][Full Text] [Related]
59. Dosimetric predictors of symptomatic radiation necrosis after five-fraction radiosurgery for brain metastases. Andruska N; Kennedy WR; Bonestroo L; Anderson R; Huang Y; Robinson CG; Abraham C; Tsien C; Knutson N; Rich KM; Spencer C; Huang J Radiother Oncol; 2021 Mar; 156():181-187. PubMed ID: 33310010 [TBL] [Abstract][Full Text] [Related]
60. Stereotactic radiosurgery of early melanoma brain metastases after initiation of anti-CTLA-4 treatment is associated with improved intracranial control. An Y; Jiang W; Kim BYS; Qian JM; Tang C; Fang P; Logan J; D'Souza NM; Haydu LE; Wang XA; Hess KR; Kluger H; Glitza IC; Mahajan A; Welsh JW; Lin SH; Yu JB; Davies MA; Hwu P; Sulman EP; Brown PD; Chiang VLS; Li J Radiother Oncol; 2017 Oct; 125(1):80-88. PubMed ID: 28916225 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]